Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Sold by Presima Securities ULC

Presima Securities ULC lowered its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 13.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 872,365 shares of the real estate investment trust's stock after selling 136,816 shares during the period. Sabra Health Care REIT makes up approximately 3.7% of Presima Securities ULC's portfolio, making the stock its 11th largest position. Presima Securities ULC owned about 0.37% of Sabra Health Care REIT worth $15,109,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Principal Financial Group Inc. raised its holdings in Sabra Health Care REIT by 0.8% in the 3rd quarter. Principal Financial Group Inc. now owns 21,573,436 shares of the real estate investment trust's stock valued at $401,479,000 after buying an additional 167,069 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock valued at $183,996,000 after acquiring an additional 6,819,919 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Sabra Health Care REIT by 1.7% in the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust's stock worth $117,165,000 after acquiring an additional 104,533 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Sabra Health Care REIT by 8.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,701,881 shares of the real estate investment trust's stock worth $87,502,000 after purchasing an additional 365,855 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Sabra Health Care REIT by 3.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust's stock valued at $52,275,000 after purchasing an additional 124,825 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Truist Financial cut shares of Sabra Health Care REIT from a "buy" rating to a "hold" rating and reduced their price target for the stock from $18.00 to $17.00 in a research report on Friday, January 17th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $16.00 to $20.00 in a report on Tuesday, October 1st. Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price objective on the stock in a research note on Tuesday, January 7th. Finally, Scotiabank boosted their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research note on Friday, October 11th. Three research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $19.13.

Sabra Health Care REIT Stock Up 1.0 %

SBRA stock traded up $0.17 during trading on Friday, hitting $16.92. 975,589 shares of the company's stock were exchanged, compared to its average volume of 1,426,103. The business has a 50-day moving average price of $17.51 and a two-hundred day moving average price of $17.56. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The stock has a market capitalization of $4.00 billion, a price-to-earnings ratio of 41.27, a PEG ratio of 2.00 and a beta of 1.26. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to analysts' expectations of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same quarter in the prior year, the firm posted $0.34 EPS. As a group, equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.09%. The ex-dividend date of this dividend was Friday, November 15th. Sabra Health Care REIT's dividend payout ratio (DPR) is currently 292.68%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.